Novo CEO pressed by Senate to cut prices of obesity, diabetic issues medication CEO Lars Fruergaard Jørgensen advised lawmakers the corporate would take into account new talks with insurers with regards to the record prices of Wegovy and copyright if they pledge to help keep the medicines on their own https://caidenzpfwm.bligblogging.com/31227901/the-smart-trick-of-healthcare-news-that-nobody-is-discussing